Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 306, Issue 7, 2014, Pages

  Alghamri, Mahmoud S ^a   Morris, Mariana ^b,d   Meszaros, J Gary ^c   Elased, Khalid M ^a   Grobe, Nadja ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b affiliation with Nova Southeastern College of Osteopathic Medicine   (United States)

^c Northeast Ohio Medical University   (United States)

^d GRECC Miami Veterans Affairs Healthcare System   (United States)

Author keywords

Aminopeptidase A; Angiotensin peptides; MALDI imaging; Myocardial infarction; Renin angiotensin system

Indexed keywords

4 AMINO 4 PHOSPHONOBUTYRIC ACID; 4 AMINOBUTYRIC ACID DERIVATIVE; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II; ANGIOTENSIN III; ANGIOTENSIN[1-7]; ANGIOTENSIN[2-7]; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTAMYL AMINOPEPTIDASE; HEART MUSCLE EXTRACT; MLN 4760; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; VASOPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME KINETICS; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME SUBSTRATE; HEART INFARCTION; HEART MUSCLE; HEART PROTECTION; HISTOPATHOLOGY; IN VITRO STUDY; INCUBATION TIME; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIMIT OF QUANTITATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; POST MYOCARDIAL INFARCTION; PRIORITY JOURNAL; REPRODUCIBILITY; SHAM PROCEDURE; TANDEM MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING;

AMINOPEPTIDASE-A; ANGIOTENSIN PEPTIDES; MALDI-IMAGING; MYOCARDIAL INFARCTION; RENIN-ANGIOTENSIN SYSTEM;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN III; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GLUTAMYL AMINOPEPTIDASE; KINETICS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTRATE SPECIFICITY; TANDEM MASS SPECTROMETRY; VENTRICULAR REMODELING;

EID: 84900535753     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00911.2013     Document Type: Article

References (51)

1. Alghamri MS, Weir NM, Anstadt MP, Elased KM, Gurley SB, Morris M. Enhanced angiotensin II-induced cardiac and aortic remodeling in ACE2 knockout mice. J Cardiovasc Pharmacol Ther 18: 138-151, 2013.
2. Bodineau L, Frugiere A, Marc Y, Claperon C, Llorens-Cortes C. Aminopeptidase A inhibitors as centrally acting antihypertensive agents. Heart Fail Rev 13: 311-319, 2008.
3. Bodineau L, Frugiere A, Marc Y, Inguimbert N, Fassot C, Balavoine F, Roques B, Llorens-Cortes C. Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension. Hypertension 51: 1318-1325, 2008.
4. Camelliti P, Devlin GP, Matthews KG, Kohl P, Green CR. Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction. Cardiovasc Res 62: 415-425, 2004.
5. Clark MA, Nguyen C, Tran H. Angiotensin III induces c-Jun N-terminal kinase leading to proliferation of rat astrocytes. Neurochem Res 37: 1475-1481, 2012.
6. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9, 2000.
7. Elased KM, Cool DR, Morris M. Novel mass spectrometric methods for evaluation of plasma angiotensin converting enzyme 1 and renin activity. Hypertension 46: 953-959, 2005.
8. Elased KM, Cunha TS, Gurley SB, Coffman TM, Morris M. New mass spectrometric assay for angiotensin-converting enzyme 2 activity. Hypertension 47: 1010-1017, 2006.
9. Erdos EG, Skidgel RA. Renal metabolism of angiotensin I and II. Kidney Int Suppl 30: S24-S27, 1990.
10. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, Santos RA, Speth RC, Sigmund CD, Lazartigues E. Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ Res 106: 373-382, 2010.
11. Ferreira AJ, Santos RA, Almeida AP. Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 38: 665-668, 2001.
12. Ferreira AJ, Santos RA, Bradford CN, Mecca AP, Sumners C, Katovich MJ, Raizada MK. Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 55: 207-213, 2010.
13. Fournie-Zaluski MC, Fassot C, Valentin B, Djordjijevic D, Reaux-Le GA, Corvol P, Roques BP, Llorens-Cortes C. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Proc Natl Acad Sci USA 101: 7775-7780, 2004.
14. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med 264: 224-236, 2008.
15. Garabelli PJ, Modrall JG, Penninger JM, Ferrario CM, Chappell MC. Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart. Exp Physiol 93: 613-621, 2008.
16. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovich MJ. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 292: H736-H742, 2007.
17. Grobe N, Elased KM, Cool DR, Morris M. Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney. Am J Physiol Endocrinol Metab 302: E1016-E1024, 2012.
18. Grobe N, Weir NM, Leiva O, Ong FS, Bernstein KE, Schmaier AH, Morris M, Elased KM. Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry. Am J Physiol Cell Physiol 304: C945-C953, 2013.
19. Healy DP, Song L. Kidney aminopeptidase A and hypertension, part I: spontaneously hypertensive rats. Hypertension 33: 740-745, 1999.
20. Huang BS, Ahmad M, White RA, Marc Y, Llorens-Cortes C, Leenen FH. Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction. Cardiovasc Res 97: 424-431, 2013.
21. Isa K, Arnold AC, Westwood BM, Chappell MC, Diz DI. Angiotensinconverting enzyme inhibition, but not AT(1) receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats. Hypertens Res 34: 1257-1262, 2011.
22. Iusuf D, Henning RH, van Gilst WH, Roks AJ. Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives. Eur J Pharmacol 585: 303-312, 2008.
23. Kono T, Taniguchi A, Imura H, Oseko F, Khosla MC. Pressor activity of angiotensin II-(2-7)-hexapeptide in man. Endocrinol Jpn 32: 767-769, 1985.
24. Lejczak B, De Choszczak MP, Kafarski P. Inhibition of aminopeptidases by phosphonic acid and phosphinic acid analogues of aspartic and glutamic acids. J Enzym Inhib 7: 97-103, 1993.
25. Lojda Z, Gossrau R. Study on aminopeptidase A. Histochemistry 67: 267-290, 1980.
26. Marc Y, Gao J, Balavoine F, Michaud A, Roques BP, Llorens-Cortes C. Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats. Hypertension 60: 411-418, 2012.
27. Marques FD, Melo MB, Souza LE, Irigoyen MC, Sinisterra RD, de Sousa FB, Savergnini SQ, Braga VB, Ferreira AJ, Santos RA. Beneficial effects of long-term administration of an oral formulation of Angiotensin-(1-7) in infarcted rats. Int J Hypertens 2012: 795452, 2012.
28. Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, Santos RA, Walther T, Touyz RM, Reudelhuber TL. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res 103: 1319-1326, 2008.
29. Nomura M, Nomura S, Mitsui T, Suzuki M, Kobayashi H, Ito T, Itakura A, Kikkawa F, Mizutani S. Possible involvement of aminopeptidase A in hypertension and renal damage in Dahl salt-sensitive rats. Am J Hypertens 18: 538-543, 2005.
30. Pinheiro SV, Simoes e Silva AC. Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney. Int J Hypertens 2012: 414128, 2012.
31. Prieto I, Hermoso F, de GM, Vargas F, Alba F, Segarra AB, Banegas I, Ramirez M. Aminopeptidase activity in renovascular hypertension. Med Sci Monit 9: BR31-BR36, 2003.
32. Qi Y, Shenoy V, Wong F, Li H, Afzal A, Mocco J, Sumners C, Raizada MK, Katovich MJ. Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology. Exp Physiol 96: 863-874, 2011.
33. Reaux A, Fournie-Zaluski MC, David C, Zini S, Roques BP, Corvol P, Llorens-Cortes C. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci USA 96: 13415-13420, 1999.
34. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Mezzano S, Egido J. Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator. Contrib Nephrol 123-137, 2001.
35. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J. Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 38: 1382-1387, 2001.
36. Schwacke JH, Spainhour JC, Ierardi JL, Chaves JM, Arthur JM, Janech MG, Velez JC. Network modeling reveals steps in angiotensin peptide processing. Hypertension 61: 690-700, 2013.
37. Song L, Healy DP. Kidney aminopeptidase A and hypertension, part II: effects of angiotensin II. Hypertension 33: 746-752, 1999.
38. Song L, Ye M, Troyanovskaya M, Wilk E, Wilk S, Healy DP. Rat kidney glutamyl aminopeptidase (aminopeptidase A): molecular identity and cellular localization. Am J Physiol Renal Fluid Electrolyte Physiol 267: F546-F557, 1994.
39. Sriramula S, Cardinale JP, Lazartigues E, Francis J. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res 92: 401-408, 2011.
40. Tan F, Morris PW, Skidgel RA, Erdos EG. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families. J Biol Chem 268: 16631-16638, 1993.
41. Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 16: 349-360, 2004.
42. Wang HX, Zhang QF, Zeng XJ, Wang W, Tang CS, Zhang LK. Effects of angiotensin III on protein, DNA, and collagen synthesis of neonatal cardiomyocytes and cardiac fibroblasts in vitro. J Cardiovasc Pharmacol Ther 15: 393-402, 2010.
43. Wolf G, Wenzel U, Assmann KJ, Stahl RA. Renal expression of aminopeptidase A in rats with two-kidney, one-clip hypertension. Nephrol Dial Transplant 15: 1935-1942, 2000.
44. Wright JW, Tamura-Myers E, Wilson WL, Roques BP, Llorens-Cortes C, Speth RC, Harding JW. Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats. Am J Physiol Regul Integr Comp Physiol 284: R725-R733, 2003.
45. Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.42411) in spontaneously hypertensive rats. Hypertension 19: 692-696, 1992.
46. Zeng WT, Chen WY, Leng XY, Tang LL, Sun XT, Li CL, Dai G. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991. Cardiovasc Ther 30: 152-161, 2012.
47. Zhao W, Zhao T, Chen Y, Sun Y. Angiotensin 1-7 promotes cardiac angiogenesis following infarction. Curr Vasc Pharmacol 2013 Apr 29. [Epub ahead of print]
48. Zini S, Demassey Y, Fournie-Zaluski MC, Bischoff L, Corvol P, Llorens-Cortes C, Sanderson P. Inhibition of vasopressinergic neurons by central injection of a specific aminopeptidase A inhibitor. Neuroreport 9: 825-828, 1998.
49. Zini S, Fournie-Zaluski MC, Chauvel E, Roques BP, Corvol P, Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 93: 11968-11973, 1996.
50. Zini S, Masdehors P, Lenkei Z, Fournie-Zaluski MC, Roques BP, Corvol P, Llorens-Cortes C. Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Neuroscience 78: 1187-1193, 1997.
51. Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR, Canver CC. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensinconverting enzyme Homologue ACE2. Circulation 108: 1707-1712, 2003.